Related Experiment Video
Updated: Aug 28, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Implementing Oral Systemic Corticosteroids for Pediatric Asthma into EMS Treatment Guidelines: A Qualitative Study
Kayla McManus1, Alexandra Cheetham2, Lauren Riney2
1Division of Pediatric Emergency Medicine, Department of Emergency Medicine, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA.
Insights
Oral corticosteroids (OCS) offer a viable alternative for pediatric asthma treatment by emergency medical services (EMS). Implementation barriers include clinician inexperience and knowledge gaps, while facilitators involve peer competition and pediatric medical director support.
Area of Science:
- Pediatric Emergency Medicine
- Implementation Science
- Health Services Research
Background:
- Respiratory distress is a common pediatric emergency, with asthma as the leading cause.
- Early corticosteroid administration in the emergency department (ED) improves outcomes for pediatric asthma.
- Emergency medical services (EMS) can facilitate earlier treatment, but intravenous (IV) access is challenging in children, making oral corticosteroids (OCS) a logical alternative.
Purpose of the Study:
- To qualitatively explore the implementation and adoption of OCS for pediatric asthma by EMS clinicians.
- To identify barriers and facilitators influencing OCS use in prehospital pediatric asthma care.
Main Methods:
- Semi-structured interviews and focus groups were conducted with EMS clinicians from diverse EMS systems.
- Transcripts were thematically coded and analyzed using the Consolidated Framework for Implementation Research (CFIR).
- The study examined 31 CFIR constructs across domains including inner setting and characteristics of individuals.
Main Results:
- Key barriers included clinician unfamiliarity with pediatric patients, dosing, and corticosteroid benefits.
- Facilitators comprised inter-agency competition, presence of a pediatric medical director, and feedback from receiving EDs.
- Implementation success was significantly influenced by EMS agency structure and individual clinician characteristics.
Conclusions:
- Implementing OCS for pediatric asthma in EMS is influenced by agency and clinician factors.
- Enhanced education on OCS benefits and pediatric-specific training for EMS clinicians is crucial for effective implementation.
- Addressing identified barriers and leveraging facilitators can improve the uptake of this evidence-based intervention.
Abstract:
Introduction: Respiratory distress accounts for approximately 14% of all pediatric emergency medical services (EMS) encounters, with asthma being the most common diagnosis. In the emergency department (ED), early administration of systemic corticosteroids decreases hospital admission and speeds resolution of symptoms. For children treated by EMS, there is an opportunity for earlier corticosteroid administration. Most EMS agencies carry intravenous (IV) corticosteroids; yet given the challenges and low rates of EMS pediatric IV placement, oral corticosteroids (OCS) are a logical alternative. However, previous single-agency studies showed low adoption of OCS. Therefore, qualitative study of OCS implementation by EMS is warranted.Methods: This study's objective was to explore uptake and implementation of OCS for pediatric asthma treatment through semi-structured interviews and focus groups with EMS clinicians. We thematically coded and analyzed transcripts using the domains and constructs of the Consolidated Framework for Implementation Research (CFIR) to identify barriers and facilitators that most strongly influenced OCS implementation and adoption by EMS clinicians.Results: We conducted five focus groups with a total of ten EMS clinicians from four EMS systems: one urban region with multiple agencies that hosted two focus groups, one suburban agency, one rural agency, and a mixed rural/suburban agency. Of the 36 CFIR constructs, 31 were addressed in the interviews. Most constructs coded were in the CFIR domains of the inner setting and characteristics of individuals, indicating that EMS agency factors as well as EMS clinician characteristics were impactful for implementation. Barriers to OCS adoption included unfamiliarity and inexperience with pediatric patients and pediatric dosing, and lack of knowledge of the benefits of corticosteroids. Facilitators included friendly competition with colleagues, having a pediatric medical director, and feedback from receiving EDs on patient outcomes.Conclusion: This qualitative focus group study of OCS implementation by EMS clinicians for the treatment of pediatric asthma found many barriers and facilitators that mapped to the structure of EMS agencies and characteristics of individual EMS clinicians. To fully implement this evidence-based intervention for pediatric asthma, more education on the intervention is required, and EMS clinicians will benefit from further pediatric training.
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

